Lipoprotein(a): Identification of subjects with a superbinding capacity for fibrinogen

Clinical Genetics

Volumn 52, Issue 5, 1997, Pages 367-370

  Scanu, Angelo M ^a   Atzeni, Maria Maddalena ^b   Edelstein, Celina ^a   Tonolo, Giancarlo ^b   Maioli, Mario ^b   Klezovitch, Olga ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Apo(a); Fibrinogen superbinders; Kringle domains; Lp(a)

Indexed keywords

APOLIPOPROTEIN A; FIBRINOGEN; LIPOPROTEIN A;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; FEMALE; HUMAN; KRINGLE DOMAIN; MALE; PRIORITY JOURNAL;

EID: 0031409383     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb04355.x     Document Type: Conference Paper

References (15)

1. Edelstein C, Italia JA, Klezovitch O, Scanu AM. Functional and metabolic differences between elastase-generated fragments of human lipoprotein(a) and apolipoprotein(a). J Lipid Res 1996: 37: 1786-1801.
2. Edelstein C, Italia JA, Scanu AM. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments. J Biol Chem 1997: 272: 11 079-11 087.
3. Edelstein C, Mandala M, Pfaffinger D, Scanu AM. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions. Biochemistry 1995: 34: 16 483-16 492.
4. Ernst A, Helmhold M, Brunner C, Pethoschramm A, Armstrong VW, Müller H-J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem 1995: 270: 6227-6234.
5. Fless GM, Snyder ML, Scanu AM. Enzyme-linked immunoassay for Lp(a). J Lipid Res 1989: 30: 651-662.
6. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989: 339: 303-305.
7. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA. 1989: 86: 3847-3851.
8. Klezovitch O, Edelstein C, Scanu AM. Evidence that the fibrinogen-binding domain of apo(a) is outside the lysine-binding site (LBS) of kringle IV-10. A study involving naturally-occurring lysine-binding defective lipoprotein(a) phenotypes. J Clin Invest 1996: 98: 185-191.
9. Klezovitch O, Scanu AM. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apolipoprotein(a) kringle IV-10 expressed in E. coli and CHO cells. Arterioscler Thromb Vasc Biol 1996: 16: 392-398.
10. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990: 10: 240-245.
11. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989: 339: 301-303.
12. Pfaffinger D, McLean L, Scanu AM. Amplification of human apo(a) kringle 4-37 from blood lymphocyte DNA. Biochim Biophys Acta 1993: 1225: 107-109.
13. Scanu AM, Edelstein C. Kringle-dependent structural and functional polymorphism of apolipoprotein(a). Biochim Biophys Acta 1995: 1256: 1-12.
14. Scanu AM, Miles LA, Fless GM, Pfaffinger D, Eisenbart J, Jackson E, Hoover-Plow JL, Brunck T, Plow EF. Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4-37. J Clin Invest 1993: 91: 283-291.
15. Scanu AM, Pfaffinger D, Lee JC, Hinman J. A single point mutation (Trp72→Arg) in human apo(a) kringle 4-37 associated with a lysine-binding defect in Lp(a). Biochim Biophys Acta 1994: 1227: 41-45.